European Medicines Agency

22.4k citations
879 papers ·

Impact in

Papers in

European Medicines Agency

714 papers receiving 17.7k citations

Peers

European Medicines Agency
Comparison fields: 5 of 217
  • Toxicology 2.3k
  • Statistics and Probability 1.5k
  • Pharmacology 1.3k
  • Economics and Econometrics 3.0k
  • Geriatrics and Gerontology 318
Replace Medicines Evaluation Board with:
Medicines Evaluation Board Netherlands
Federal Institute for Drugs and Medical Devices Germany
Netherlands Pharmacovigilance Centre Lareb Netherlands
Dutch Health Care Inspectorate Netherlands
European Organisation for Research and Treatment of Cancer Netherlands
Bristol-Myers Squibb (Switzerland) Switzerland
Farr Institute United Kingdom
Janssen (Netherlands) Netherlands
Centre d’Investigation Clinique Innovation Technologique de Nancy France
GlaxoSmithKline (Germany) Germany
European Medicines Agency relative to Medicines Evaluation Board Netherlands Medicines Evaluation Board's profile →
Citations per field
00.5×2×2.8×
Medicines Evaluation Board · 1×
Citations per year

Countries citing scholars working at European Medicines Agency

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at European Medicines Agency. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at European Medicines Agency with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites European Medicines Agency more than expected).

Fields of papers published by authors at European Medicines Agency

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with European Medicines Agency at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with European Medicines Agency at the time of their publication.

About European Medicines Agency

In recent decades, authors affiliated with European Medicines Agency have published 879 papers, which have received a total of 22.4k indexed citations . Scholars at this organization have produced 93 papers in Toxicology, 86 papers in Statistics and Probability, 230 papers in Economics and Econometrics, 57 papers in Pharmacology and 102 papers in Pediatrics, Perinatology and Child Health on the topics of Health Systems, Economic Evaluations, Quality of Life (182 papers), Pharmaceutical Economics and Policy (109 papers), Pharmaceutical studies and practices (93 papers), Pharmacovigilance and Adverse Drug Reactions (90 papers), Statistical Methods in Clinical Trials (77 papers), Biosimilars and Bioanalytical Methods (73 papers), Biomedical Ethics and Regulation (49 papers) and Pharmaceutical industry and healthcare (32 papers). Their work is cited by papers focused on Toxicology (2.3k citations), Statistics and Probability (1.5k citations), Pharmacology (1.3k citations), Economics and Econometrics (3.0k citations) and Geriatrics and Gerontology (318 citations). Authors at European Medicines Agency collaborate with scholars in Netherlands, United Kingdom and United States and have published in prestigious journals including Clinical Pharmacology & Therapeutics, Drug Safety, British Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety and Nature Reviews Drug Discovery. Some of European Medicines Agency's most productive authors include John A. Lewis, Patrick Waller, Stephen Evans, Sarah Davis, Elliot G. Brown, Sue Wood, Rashmi R. Shah, Joanne Barnes, J. David Phillipson and Linda A. Anderson.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact